Effective treatment of edema and endothelial barrier dysfunction with imatinib.
about
Abl family kinases regulate endothelial barrier function in vitro and in micePharmacological treatment options for mast cell activation diseaseAbl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survivalImpedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurementsLocalized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity.Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion.Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrityCooperative signaling via transcription factors NF-κB and AP1/c-Fos mediates endothelial cell STIM1 expression and hyperpermeability in response to endotoxin.Role of pore-forming toxins in bacterial infectious diseases.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction.Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injuryThe tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice.Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.New paradigms in sepsis: from prevention to protection of failing microcirculation.Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches.Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities.Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility.CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs).VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.Ginsenoside Rb1 ameliorates lipopolysaccharide-induced albumin leakage from rat mesenteric venules by intervening in both trans- and paracellular pathway.A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway.Reversal of vascular leak with imatinib.The vascular endothelial specific IL-4 receptor alpha-ABL1 kinase signaling axis regulates the severity of IgE-mediated anaphylactic reactions.Relationship of Cx43 regulation of vascular permeability to osteopontin-tight junction protein pathway after sepsis in rats.A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation.Insulin Receptor Substrate 2 Controls Insulin-Mediated Vasoreactivity and Perivascular Adipose Tissue Function in Muscle.Reply: Reversal of vascular leak with imatinib: a role for IL-2?Reversal of vascular leak with imatinib: a role for IL-2?Phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 regulates epinephrine-induced exocytosis of Weibel-Palade bodies.Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.Prolonging Gastrointestinal-Stromal-Tumor-free life, an optimal suggestion of imatinib intervention ahead of operationTargeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma SeedsSchisandrin Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating TLR-4 and Akt/FoxO1 Signaling Pathways
P2860
Q24316240-88D884F3-AC82-48B7-A650-58280022C0F7Q26748784-6ACD43BA-ACFA-48B2-B2A7-2BAF30A092E1Q28586705-A898D7C4-68C6-4072-9690-D11E4072BCBBQ30373402-868C74FB-6D74-4E97-A89E-7E7E509FF443Q30557918-A9D462F2-1C7E-4F78-8331-B8F25208CD5EQ33610580-377B2CDD-441C-4D1C-930A-3E1C6D44F5AFQ33753767-DBC36747-1259-4FFE-B907-E0566E4301F1Q34107201-F8D4E399-A11F-43D8-8B15-58A423E01584Q34346202-DEA75435-8794-4951-B96E-EBE93D4B1E48Q34352802-3833E057-E532-4365-8863-952A6944E864Q35115797-322C6D76-E742-415E-A1CD-A08397449A1FQ36071422-D4EDEDF8-0248-4B5D-9D99-725D9F5208ACQ36306823-0ABE67BB-F1DE-4FB6-909F-C610FEEC29FEQ36345868-34330DC5-B8BC-4073-9FC0-56349FC89614Q36357495-07E47E82-F65A-4AEA-963D-6CD8E7A4C0E1Q36755620-294A5053-A4E6-4233-AD75-311785CCF85CQ37238202-4AFE3518-A064-4563-8F8C-86669FADDD2DQ37629029-58EAA9C3-5B71-4CD9-B28C-33D2E45CE2F1Q38192536-DD927050-1D68-4904-9C7C-2579B57C02B1Q38193705-0C9F0FD3-EAA0-4634-9DF4-44174E400B74Q38770657-A2404F15-DEB9-4107-9A52-1DB060229985Q38813467-548C8214-DB1C-45B8-B66B-729594E7696DQ38876661-B2BF4F21-938F-41D7-BEEC-8DFFE38F2A58Q41769327-D383B259-C5FB-4503-8982-01E363F7402DQ42043630-EF672AAC-E9FC-4933-A6B0-B2351C8CEB55Q42292864-D71D8363-A2AF-4E2B-A53F-95BDC042192AQ43622238-324E6B09-9C38-409A-9F7D-5C10754D3199Q46573219-5F54A5ED-5ED8-4971-84D8-7EB76B9BBBB9Q46802205-7F70678C-CF5A-431B-B805-727C5D8111C1Q47575091-DEE7EE74-17B0-4356-A9B4-E170BE70FD67Q47697245-67E28ED8-1070-4832-B44F-342D2AE8E725Q52650349-0093A1DF-F95A-4868-97FC-5D4A806A1AE8Q53697383-FC5F725F-D7FA-4CEE-B75A-4E2CAC16D7BAQ54340901-6DB8C91F-95B2-499B-A6CD-D9CD6CD44B92Q54340903-EBE4D00A-5063-456F-A13C-5ABBB8842C56Q54394032-CBBD3CFE-361D-42DE-8ACC-2D889AFD2FEDQ55264050-61FD0858-1C46-4B72-ABBA-32A758437C3AQ58582206-DDDF4074-D6F4-4279-93DE-5195F2723F15Q58775472-D1D949EF-505C-49D7-BCEB-5241C80C3F06Q58795209-C26CD041-F4EB-494D-A97F-4653692C7B20
P2860
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@en
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@nl
type
label
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@en
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@nl
prefLabel
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@en
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
@nl
P2093
P1433
P1476
Effective treatment of edema and endothelial barrier dysfunction with imatinib
@en
P2093
A B Johan Groeneveld
Amin Damanafshan
Anton Vonk Noordegraaf
Geerten P van Nieuw Amerongen
Jan van Bezu
Jurjan Aman
Steven M Vogel
Victor W M van Hinsbergh
P304
P356
10.1161/CIRCULATIONAHA.112.134304
P407
P577
2012-10-25T00:00:00Z